Bandingkan Harga & Kinerja Radana Bhaskara Finance Tbk. (HDFA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Radana Bhaskara Finance Tbk. dan Organon Pharma Indonesia Tbk.: Radana Bhaskara Finance Tbk. diperdagangkan di Rp100 (kapitalisasi pasar 660,79 M, volume 24 jam 428 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Radana Bhaskara Finance Tbk. jauh lebih besar — sekitar 6,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HDFA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 660,79 M | 104,4 M |
Volume | 428 rb | — |
Lot | 4,28 rb | — |
Perputaran | 42,84 jt | — |
Harga Rata-rata | 100,09 | — |
Nilai Transaksi | 42,84 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Radana Bhaskara Finance Tbk.
PT HD Finance (the company) was incorporated under the name of PT Indonesia Lease Corporation base on notarial deed No.41 of Mr FA Tumbuan, S.H, dated 20 Sep, 1972. The Company's name has been changed from PT HD Finance Tbk to PT Radana Bhaskara Finance Tbk based on the Notarial Deed No. 136 dated May 21, 2014 of Jimmy Tanal, S.H., M.Kn.
Selengkapnya di halaman HDFA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
